Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine and mupirocin decolonization to prevent neutropenic fever in acute leukemia
IRCT20160310026998N6Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Feb 2018
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of chlorhexidine and mupirocin in febrile neutropenia (FN) (3 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Rate of neutropenic fever. Started Feb 2018; status: completed.
02
Drugs
chlorhexidinemupirocin
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on IRCT20160310026998N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160310026998N6.